Abbott Laboratories will release about 300,000 cans of a specialty infant formula for children in urgent medical need, while U.S. health regulators cleared the import of about 2 million cans of formula from the U.K. to try to mitigate a shortage.

Abbott, of Abbott Park, Ill., said Tuesday it is releasing limited quantities of EleCare, an amino acid-based powder for infants with severe food allergies or gastrointestinal disorders.

This post first appeared on wsj.com

You May Also Like

How many booster shots will you need? FDA panel to discuss Covid plans for fall

Food and Drug Administration advisers will meet Wednesday to hash out what…

3M Agrees to Combine Its Food-Safety Unit With Neogen

3M Corp. MMM -1.42% on Tuesday agreed to combine its food-safety business…

Coxsackie, N.Y.: ‘A Special Place on the Hudson’

Joel Readence fell in love with the house first. In May 2021,…

Family of New York woman missing on road trip says fiancé ‘refuses to help’ find her

The family of the New York woman who went missing while on…